Ghent University Academic Bibliography

Advanced

Irbesartan is projected to be cost and life saving in the French setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria

AJ Palmer, Lieven Annemans UGent, S Roze, M Lamotte, P Lapuerta, S Gabriel, R Chen, P Carita, I Vialladary, R Rodby, et al. (2003) VALUE IN HEALTH. 6(6). p.615-616
Please use this url to cite or link to this publication:
author
organization
year
type
conference (meetingAbstract)
publication status
published
subject
in
VALUE IN HEALTH
Value Health
volume
6
issue
6
pages
615 - 616
Web of Science type
Meeting Abstract
Web of Science id
000186300900029
ISSN
1098-3015
language
English
UGent publication?
yes
classification
C3
id
306078
handle
http://hdl.handle.net/1854/LU-306078
date created
2005-05-13 11:37:00
date last changed
2017-01-30 12:47:57
@inproceedings{306078,
  author       = {Palmer, AJ and Annemans, Lieven and Roze, S and Lamotte, M and Lapuerta, P and Gabriel, S and Chen, R and Carita, P and Vialladary, I and Rodby, R and De Zeeuw, D and Parving, HH},
  booktitle    = {VALUE IN HEALTH},
  issn         = {1098-3015},
  language     = {eng},
  number       = {6},
  pages        = {615--616},
  title        = {Irbesartan is projected to be cost and life saving in the French setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria},
  volume       = {6},
  year         = {2003},
}

Chicago
Palmer, AJ, Lieven Annemans, S Roze, M Lamotte, P Lapuerta, S Gabriel, R Chen, et al. 2003. “Irbesartan Is Projected to Be Cost and Life Saving in the French Setting for Treatment of Patients with Type 2 Diabetes, Hypertension, and Microalbuminuria.” In Value in Health, 6:615–616.
APA
Palmer, A., Annemans, L., Roze, S., Lamotte, M., Lapuerta, P., Gabriel, S., Chen, R., et al. (2003). Irbesartan is projected to be cost and life saving in the French setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria. VALUE IN HEALTH (Vol. 6, pp. 615–616).
Vancouver
1.
Palmer A, Annemans L, Roze S, Lamotte M, Lapuerta P, Gabriel S, et al. Irbesartan is projected to be cost and life saving in the French setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria. VALUE IN HEALTH. 2003. p. 615–6.
MLA
Palmer, AJ, Lieven Annemans, S Roze, et al. “Irbesartan Is Projected to Be Cost and Life Saving in the French Setting for Treatment of Patients with Type 2 Diabetes, Hypertension, and Microalbuminuria.” Value in Health. Vol. 6. 2003. 615–616. Print.